This content was prepared in compliance with the Medical Service Act and related regulations.


What Makes a Difference When Combining Hyperbaric Oxygen Therapy with Stem Cell Treatment?

3 Key Takeaways
• Hyperbaric oxygen therapy (HBOT) is being studied as an auxiliary therapy that creates an oxygen environment conducive to stem cell activity.
• When combined in pilot clinical trials, signals of improved recovery indicators were confirmed, but large-scale clinical trials for aesthetic and regenerative purposes are still lacking.
• Whether to combine the two depends on the purpose, health status, and type of procedure, so consultation with a specialist is essential beforehand.

Recently, more and more people are curious about what benefits can be expected when receiving stem cell treatment and hyperbaric oxygen therapy together. To answer directly, combining the two therapies is an approach where some potential has been confirmed in the research stage, but it has not yet been established as a standard clinical protocol at this time.

In a pilot clinical trial published in ASTCT (American Society for Transplantation and Cellular Therapy) journal Biology of Blood and Marrow Transplantation (2019), signals were confirmed that combining HBOT with autologous hematopoietic stem cell transplantation is clinically applicable, and the possibility of contributing to improved recovery time for neutrophils and platelets was suggested. However, that clinical trial also explicitly states that "additional research is needed."

Hyperbaric oxygen therapy itself is a treatment in which pure oxygen is inhaled in an environment of 1 atmosphere or higher, with the core mechanism being to increase the oxygen partial pressure in blood and tissues. How this change in oxygen environment may affect stem cell mobilization and proliferation is a topic of attention in the regenerative medicine field. However, according to related clinical data, reports of human research indicators related to progenitor cell mobilization are still limited, and more clinical evidence is needed for application to aesthetic and regenerative purposes.


The Mechanism by Which Hyperbaric Oxygen Therapy Acts on Stem Cells — What Kind of Environment Does It Create?

Understanding how HBOT can interact with stem cells in which ways provides practical help in determining whether to combine the treatments. Let's examine the main mechanisms step by step.

• Creating an Environment for Stem Cell Proliferation

In a preclinical study published in PubMed (PMC6078002), results were reported showing that HBOT increased the proliferation rate of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC) and showed a synergistic effect on wound healing in diabetic mouse models. Activation of angiogenic promotion pathways was presented as a key mechanism.

• Anti-inflammatory and Cellular Protection Effects

There are reports that HBOT has strong anti-inflammatory and anti-apoptotic properties, which can contribute to suppressing the spread of cell death in damaged areas. In relation to this, animal research published on ScienceDirect confirmed results showing that combining stem cell exosomes with HBOT showed synergistic effects on spinal cord injury recovery.

• Improved Oxygen Delivery Efficiency

HBOT dissolves much more oxygen in plasma than in normal conditions, making it possible to deliver oxygen to tissues deep inside that would be difficult to reach with normal oxygen supply.

• Assistance with Collagen Synthesis and Angiogenesis

Contribution to angiogenesis promotion and increased collagen production are items repeatedly mentioned in multiple studies.

However, most of the above mechanisms are results derived from animal experiments or research on specific diseases (diabetic ulcers, spinal cord injuries, etc.). To expect the same effects when combining stem cell treatments for aesthetic and anti-aging purposes, accumulation of additional clinical evidence is necessary, and a cautious approach is recommended at this stage.


What 21plastic surgery Examines Together When Considering Regenerative and Recovery Procedures in Gangnam

The most important thing to confirm first when planning a procedure for regenerative purposes is the evidence level of the procedure and your own suitability.

In a scholarly commentary published in Journal of the Korean Medical Association (JKMA), it is pointed out that the boom surrounding stem cells often stems from failing to recognize stem cells not as 'completed therapeutic agents' but as 'technology in the process of research and development,' and it emphasizes that we must recognize that stem cells are currently in the 'testing' phase rather than the 'procedure' stage. International guidelines also specify the obligation to provide sufficient disclosure to patients before efficacy confirmation.

Below is an organized list of key items that need to be confirmed when considering combining stem cell procedures with HBOT.

Confirmation ItemContent to Review
Purpose of TreatmentEvidence level varies depending on whether it is for aesthetic purposes, regeneration, or disease treatment
Domestic Approval StatusIt is essential to confirm whether stem cell products have been approved by the MFDS
HBOT Application SuitabilityDecision on whether to proceed made after evaluation of medical history and diagnostic results
Timing of CombinationDetermine which method—HBOT preceding, concurrent, or following—has been studied
Treatment ProviderConfirm the legality of the medical institution and qualifications of medical staff

21plastic surgery pursues a systematic consultation that examines treatment evidence and suitability together while focusing on individual harmony. Based on experience discussing total cosmetic solutions with diverse patients at home and abroad, we recommend evidence-based approaches even when choosing procedures for regenerative and recovery purposes.


Before Stem Cell Treatment, Those Meeting These Criteria Must Confirm First

Before deciding on combined treatment, please review the following checklist first. An accurate information check is the starting point for safe choices.

• Have you confirmed domestic MFDS approval status?
Unapproved stem cell products have not undergone official review for quality, safety, purity, or potency. Be sure to confirm the approval status of the product before treatment.

• Are you fully aware of the possibility of side effects?
According to official FDA guidance, serious adverse reactions including blindness, tumor formation, and infection have been officially reported following use of unapproved stem cell products.

• Have you checked HBOT contraindications in advance?
As also specified in Apollo Hospital's clinical recommendations, the decision to perform hyperbaric oxygen therapy must be made after thorough evaluation of the patient's medical history, symptoms, and diagnostic results. Prior confirmation is especially important if you have lung-related conditions or are taking certain medications.

• Are you familiar with post-treatment precautions?
After HBOT, it is generally recommended to avoid activities that may generate additional reactive oxygen species, such as saunas, jjimjilbangs (Korean spas), and excessive aerobic exercise for a period of time.

• Have you confirmed that the treatment facility is a legitimate medical institution?
Since numerous facilities worldwide provide unvalidated stem cell procedures, you must confirm the legality of the medical institution and the qualifications of medical staff.

For those in the Gangnam, Sinnonhyeon, Seocho, and Yeoksam areas exploring regenerative procedures, it is recommended that you first have a consultation with a specialist and check the domestic approval status before proceeding with treatment.


Questions About Regenerative and Recovery Procedures — 21plastic surgery Helps Organize Them Together with You

At 21plastic surgery, before regenerative treatment, we first examine your health status and purpose together with you. In a convenient location between Sinnonhyeon Station and Gangnam Station, both domestic and international patients can receive systematic, evidence-based consultations.

The pilot clinical study in the ASTCT journal and other academic literature on combination therapies suggest positive possibilities while consistently concluding that "additional research is needed." Slowly and carefully examining things together based on verified information is the safest first step. Once you've made up your mind to change, we'll be there to start that journey safely with you.


Stem Cell and Hyperbaric Oxygen Combination Treatment, Frequently Asked Questions

Q1. Is it true that hyperbaric oxygen therapy increases the number of stem cells in your body?

It is true that some preclinical studies have reported results suggesting that HBOT can have a positive effect on stem and progenitor cell mobilization. However, expressing this as "cells increase several-fold" could be an exaggeration that exceeds the current level of clinical evidence. Since individual response may vary depending on personal circumstances, it is important to set accurate expectations through consultation with a specialist.

Q2. Can stem cell treatment be legally received in Korea?

In Korea, use of stem cell therapies approved by the MFDS is permitted for specific indications only. Treatment using stem cell products with unverified safety and efficacy is very limited in scope, and there is also uncertainty regarding the cell processing procedure and injection. If you are considering this procedure, you must first confirm whether the product has been approved domestically.

Q3. Are there any precautions when receiving stem cell treatment after hyperbaric oxygen therapy?

In the pilot clinical trial, the protocol was structured to perform HBOT first and then administer stem cells after a certain time elapsed. However, this is a specialized protocol designed for hematopoietic stem cell transplant patients, and additional evidence is needed to apply it identically to general aesthetic and regenerative purposes. The order and interval of procedures must be determined only after thorough consultation with your medical team.


Non-covered medical treatment fees are displayed and guided in-house according to Article 45 of the Medical Service Act.